Co-targeting HSP90 alpha and CDK7 overcomes resistance against HSP90 inhibitors in BCR-ABL1+ leukemia cells.
Vogt M, Dienstbier N, Schliehe-Diecks J, Scharov K, Tu JW, Gebing P, Hogenkamp J, Bilen BS, Furlan S, Picard D, Remke M, Yasin L, Bickel D, Kalia M, Iacoangeli A, Lenz T, Stühler K, Pandyra AA, Hauer J, Fischer U, Wagener R, Borkhardt A, Bhatia S.
Vogt M, et al. Among authors: tu jw.
Cell Death Dis. 2023 Dec 6;14(12):799. doi: 10.1038/s41419-023-06337-3.
Cell Death Dis. 2023.
PMID: 38057328
Free PMC article.